Sigmund, A. M., Sahasrabudhe, K. D., & Bhatnagar, B. (2020). Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Blood Lymphat Cancer.
Citação norma ChicagoSigmund, Audrey M., Kieran D. Sahasrabudhe, and Bhavana Bhatnagar. "Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy." Blood Lymphat Cancer 2020.
Citação norma MLASigmund, Audrey M., Kieran D. Sahasrabudhe, and Bhavana Bhatnagar. "Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy." Blood Lymphat Cancer 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.